A continuous postoperative sivelestat infusion reduced ARDS rates versus placebo after cardiovascular surgery (16.8% vs 31.2%; P < .001). Ninety-day all-cause mortality was lower with sivelestat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results